Page 29 - ARNM-2-1

Advances in Radiotherapy
& Nuclear Medicine Is 5-mm PTV margin 4D-CT-based radiotherapy

population-based PTV margin. However, daily online image consolidation carboplatin plus paclitaxel with or without
guidance or at least a well-defined offline image guidance cetuximab for patients with stage IIIA or IIIB non-small-
protocol with such small PTV margins is recommended. cell lung cancer (RTOG 0617): A randomised, two-by-two
factorial phase 3 study. Lancet Oncol. 2015;16(2):187-199.
Acknowledgments doi: 10.1016/S1470-2045(14)71207-0
The authors acknowledge the support and hard work of all 2. Curran WJ Jr., Paulus R, Langer CJ, et al. Sequential vs.
colleagues. Concurrent chemoradiation for stage III non-small cell
lung cancer: Randomized phase III trial RTOG 9410. J Natl
Funding Cancer Inst. 2011;103(19):1452-1460.

None. doi: 10.1093/jnci/djr325
Conflict of interest 3. Fournel P, Robinet G, Thomas P, et al. Randomized phase
III trial of sequential chemoradiotherapy compared
The authors declare that they have no competing interests. with concurrent chemoradiotherapy in locally advanced
non-small-cell lung cancer: Groupe Lyon-Saint-
Author contributions Etienne d’Oncologie Thoracique-Groupe Français de
Conceptualization: Animesh Saha, Aditi Mishra, Biplab Pneumo-Cancérologie NPC 95-01 study. J Clin Oncol.
2005;23(25):5910-5917.
Sarkar
Formal analysis: Animesh Saha, Suchanda Goswami, doi: 10.1200/JCO.2005.03.070
Mousin Gazi 4. Ashworth A, Rodrigues G, Boldt G, Palma D. Is there
Investigation: Animesh Saha, Aditi Mishra, Shreya Manna, an oligometastatic state in non-small cell lung cancer?
Ajay Banik, Jibak Bhattacharya, Prosenjit Soren, A systematic review of the literature. Lung Cancer.
Sayantan Mondal, Suvra Biswal 2013;82(2):197-203.
Methodology: Animesh Saha, Aditi Mishra, Shreya Manna, doi: 10.1016/j.lungcan.2013.07.026
Ajay Banik, Suchada Goswami,
Tanmoy Mukhopadhay, Saptaswa Chattopadhyay, Kiruba 5. Din OS, Harden SV, Hudson E, et al. Accelerated
George hypo-fractionated radiotherapy for non small cell lung
Writing – original draft: Animesh Saha, Aditi Mishra cancer: Results from 4 UK centres. Radiother Oncol.
2013;109(1):8-12.
Writing – review & editing: Animesh Saha, Sandipan Roy
Chowdhury. doi: 10.1016/j.radonc.2013.07.014
Ethics approval and consent to participate 6. Faivre-Finn C, Snee M, Ashcroft L, et al. Concurrent once-
daily versus twice-daily chemoradiotherapy in patients with
Ethical committee approval was obtained for this study. limited-stage small-cell lung cancer (CONVERT): An open-
The reference number is IEC Ref: IEC/2021/DNB/04/17, label, phase 3, randomised, superiority trial. Lancet Oncol.
and the approval date was 03.04.2021. The approval letter 2017;18(8):1116-1125.
from the ethics committee is attached separately. Informed doi: 10.1016/S1470-2045(17)30318-2
consent was obtained from all participants. Informed 7. Le Chevalier T, Arriagada R, Tarayre M, et al. Significant
consent forms were attached separately. effect of adjuvant chemotherapy on survival in locally

Consent for publication advanced non-small-cell lung carcinoma. J Natl Cancer Inst.
1992;84(1):58.
Consent for study publication has been obtained from doi: 10.1093/jnci/84.1.58
the study participants, and their identities have not been
disclosed anywhere in this article. 8. ICRU. ICRU Report 62: Prescribing, Recording and Reporting
Photon Beam Therapy (Supplement to ICRU 50). Available
Availability of data from: https://www.icru.org/report/prescribing-recording-
and-reporting-photon-beam-therapy-report-62
The data are presented in Excel format with the authors
(Dr. Animesh Saha and Dr. Aditi Mishra) which can be 9. Chen QS, Weinhous MS, Deibel FC, Ciezki JP, Macklis RM.
Fluoroscopic study of tumor motion due to breathing:
shared if required.
Facilitating precise radiation therapy for lung cancer
References patients. Med Phys. 2001;28(9):1850-1856.
doi: 10.1118/1.1398037
1. Bradley JD, Paulus R, Komaki R, et al. Standard-dose versus
high-dose conformal radiotherapy with concurrent and 10. Keall PJ, Mageras GS, Balter JM, et al. The management of

Volume 2 Issue 1 (2024) 8 https://doi.org/10.36922/arnm.2784